An interventional study of Motivational Interviewing Training in Hepatitis C, sponsored by Nova Scotia Health Authority. Terminated at 1 site in Canada. Per ClinicalTrials.gov, last updated 2023-02-10.
Sponsored by Nova Scotia Health Authority · Not applicable, Interventional, and Other
This study addresses a difficult barrier to hepatitis C elimination, specifically development and maintenance of a productive relationship between the health care provider and patient to ensure both treatment success and engagement in harm reduction services. Improvements in these domains may be observed through the use of a technique called "Motivational Interviewing" (MI). The aim of this study is to determine whether a customized motivational interviewing curriculum by general primary care and addictions medicine primary care providers changes rates of curative hepatitis C therapy completion.
2,321 studies on the registry are indexed under Hepatitis C; 102 are open to participants now.
This study's enrollment of 2 is below the median of 79 across 1,633 interventional studies indexed under Hepatitis C.
Browse Hepatitis C studies →Nova Scotia Health Authority is the lead sponsor of 255 studies on the registry; 76 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient Inclusion Criteria:
Patient Exclusion Criteria:
Health Care Provider Inclusion Criteria:
Health Care Provider Exclusion Criteria:
Health care providers will be trained in motivational interviewing for use in Hepatitis C patient encounters.
Behavioral: Motivational Interviewing Training
Health care providers will not be trained in motivational interviewing for use in Hepatitis C patient encounters.
Motivational Interviewing is a directive, client-centered counselling style intended to elicit behavior change by helping patients reach health goals through their own desires and actions. A certified and experienced Motivational Interviewing trainer will develop and deliver the curriculum to healthcare providers.
HCV Treatment Completion
To measure the number of patients who complete HCV therapy
Time frame: Through study completion, an average of 2 years
Time from care engagement to treatment initiation
Time frame: Through study completion, an average of 2 years
Number of unique Hepatitis C related and unrelated health system visits
Time frame: Through study completion, an average of 2 years
Number of scheduled and attended medical care appointments
Time frame: Through study completion, an average of 2 years
Self-reported intent to initiate and maintain HCV treatment assessed by questionnaire
Time frame: Through study completion, an average of 2 years
Healthcare provider knowledge, attitudes, and behavior about motivational interviewing and training assessed by questionnaire
Time frame: Through study completion, an average of 2 years
Time to complete prescribed HCV treatment course
Time frame: Through study completion, an average of 2 years
Percentage of eligible individuals that initiate HCV therapy
Time frame: Through study completion, an average of 2 years
Plan to share: No
No publications or documents are linked to this record.
This study is terminated, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nova Scotia Health Authority